Added to YB: 2021-09-13
Pitch date: 2021-09-13
SBTX:US [bearish]
Silverback Therapeutics, Inc.
+61.05%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of November 8, 2022, Silverback Therapeutics, Inc. was acquired by ARS Pharmaceuticals, Inc., in a reverse merger transaction.
Market Cap
$210.6M
Pitch Price
$15.07
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.73
P/E
-2.41
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
Silverback Therapeutics, Inc. SBTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)